We are live on
!
Find out more
CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI
Delisted
CSCI was delisted on the 3rd of September, 2025.
20 hedge funds and large institutions have $434K invested in COSCIENS Biopharma Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
25% more funds holding
Funds holding: 16 → 20 (+4)
0.01% less ownership
Funds ownership: 0.03% → 0.02% (-0.01%)
22% less capital invested
Capital invested by funds: $555K → $434K (-$121K)
Holders
20
Holders Change
+4
Holders Change %
+25%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
2
Closed
3
Calls
$73K
Puts
–
Net Calls
+$73K
Net Calls Change
+$13K
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$20.5K |
| 2 |
Two Sigma Advisers
New York
|
+$10.7K |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$10.5K |
| 4 |
RFA
Reilly Financial Advisors
La Mesa,
California
|
+$2.22K |
| 5 |
TC
Truvestments Capital
Sarasota,
Florida
|
+$814 |
